title: [Isolation of Staphylococcus aureus hetero-resistant to vancomycin (hVISA) in the Regional Hospital of Concepción, Chile].
abstract: Methicillin-resistant Staphylococcus aureus (MRSA) is widely distributed in hospital environments, causing serious infections, mainly the bloodstream, surgical site infection and pneumonia. Vancomycin (VAN) is the antibiotic of choice for treating severe MRSA infections; however, nowadays worldwide resistant strains (VRSA), with intermediate susceptibility (VISA) and decreased susceptibility or hetero-resistance to VAN (hVISA) have been reported, related to treatment failure and increased mortality. This report describes the first confirmed isolation of MRSA with hVISA phenotype in a public hospital in Chile.
authors.forename: Félix
authors.initials: F
authors.lastname: Vega
authors.forename: Pedro
authors.initials: P
authors.lastname: Alarcón
authors.forename: Mariana
authors.initials: M
authors.lastname: Domínguez
authors.forename: Helia
authors.initials: H
authors.lastname: Bello
authors.forename: Gisela
authors.initials: G
authors.lastname: Riedel
authors.forename: Sergio
authors.initials: S
authors.lastname: Mella
authors.forename: Alejandro
authors.initials: A
authors.lastname: Aguayo
authors.forename: Gerardo
authors.initials: G
authors.lastname: González-Rocha
mesh_terms: D002677:Chile; D052978:Disk Diffusion Antimicrobial Tests; D005260:Female; D006801:Humans; D055624:Methicillin-Resistant Staphylococcus aureus / Q000187:drug effects* / Q000302:isolation & purification; D008875:Middle Aged; D013203:Staphylococcal Infections / Q000382:microbiology*; D020713:Vancomycin Resistance